FIELD: pharmacology.
SUBSTANCE: conjugate of the invention is a compound of formula (C6O4H9NH2)m(C6O4H9NHX)n, wherein the remainder of the polyethylene glycol derivative, which is a monomethoxy-PEG succinate acts as a substituent on the amino group X, the molecular weight of chitosan used to prepare the conjugate is 15 to 120,000 daltons, am and n are the number of units in the molecule, where m/n is 6 to 19. The proposed method involves preparation of a solution of N-hydroxysuccinimide ester of PEG-hemisuccinate in dimethylformamide or dimethylsulfoxide, mixing of the solution prepared with an acidic solution of chitosan with a molecular weight of 15-120 kDa, and adjustment of the resulting mixture to a pH of 7.5-8.0, followed by purification by dialysis against buffer solution.
EFFECT: new substance effective for liposomal suspensions stabilization is disclosed, and an effective method for its preparation.
3 cl, 3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR DELIVERY OF ACTIVE AGENT | 2017 |
|
RU2669354C1 |
TRANSPULMONARY LIPOSOME FOR CONTROLLING DRUG DELIVERY | 2008 |
|
RU2493874C2 |
LIPOSOMAL COMPOSITIONS AND SOLID PERORAL MEDICINAL FORMS COMPRISING SUCH COMPOSITIONS | 2018 |
|
RU2751192C2 |
LIPOSOME SUSPENSION STABILISER AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2529179C1 |
PREORAL DELIVERY SYSTEM FOR PROTEIN SUBSTANCE (OPTIONS), PROTECTIVE COATING FOR DELIVERY SYSTEM (OPTIONS) | 2014 |
|
RU2665367C2 |
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 |
|
RU2482837C2 |
DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
TARGETING AMINOACID LIPIDS | 2013 |
|
RU2654210C2 |
Authors
Dates
2018-01-26—Published
2015-01-30—Filed